Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 30;14(1):36.
doi: 10.1186/s13099-022-00511-2.

Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes

Rachel Bernard  1 , Muhammad B Hammami  2   3 , Forest W Arnold  4 , Brian Mcgrath  5 , Alieysa Patel  6 , Brandon Wuerth  5 , Maribeth R Nicholson  1 , Krishna Rao  6 , Dejan Micic  7
Affiliations

Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes

Rachel Bernard et al. Gut Pathog. .

Abstract

Introduction: Clostridioides difficile infection (CDI) rates and outcomes can vary based on differences in testing strategy. Our aim was to assess the prevalence of toxin detection in inflammatory bowel disease (IBD) when compared to those without IBD. Secondly, the clinical outcomes of CDI in IBD were assessed using two-step testing strategies.

Methods: We included patients undergoing CDI testing from four academic centers in the United States between January 1, 2018 and June 30, 2020. First the prevalence of toxin detection was compared between individuals with IBD and those without IBD. Secondly, among patients with IBD a primary composite outcome of abdominal colectomy, admission to an intensive care unit (ICU) or death within 30 days of C. difficile testing was assessed across the three categorical groups (screen positive/toxin positive, screen positive/toxin negative and screen negative assay) resulting from the two-step testing strategy.

Results: When comparing individuals with a positive screening assay, patients with IBD were less likely to have toxin detected by enzyme immunoassay (EIA) as compared to the non-IBD population (22/145 (15.2%) vs. 413/1144 (36.1%), p < 0.0001). Among all patients with IBD (n = 300), twenty-five (8.3%) had a screen positive assay/toxin positive assay, 136 (45.3%) had a screen positive/toxin negative assay and 139 (46.3%) had a negative screening assay. No significant difference in the primary composite outcome was detected across the three groups (p = 0.566).

Conclusion: When compared to those without IBD, patients with IBD have a reduced proportion of cases of C. difficile with toxin positivity. Differences in clinical outcomes among patients with IBD were not detected and limited by the infrequent detection of expressed toxin.

Keywords: Clostridium difficile; Colitis; Inflammatory bowel disease.

PubMed Disclaimer

Conflict of interest statement

No expressed conflicts of interest with respect to the submitted work.

References

    1. Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, et al. Risk factors for Clostridium difficile isolation in inflammatory bowel disease: a prospective study. Dig Dis Sci. 2018;63(4):1016–1024. doi: 10.1007/s10620-018-4941-7. - DOI - PubMed
    1. Rodemann JF, Dubberke ER, Reske KA, da Seo H, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5(3):339–344. doi: 10.1016/j.cgh.2006.12.027. - DOI - PubMed
    1. Polage CR, Gyorke CE, Kennedy MA, Leslie JL, Chin DL, Wang S, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med. 2015;175(11):1792–1801. doi: 10.1001/jamainternmed.2015.4114. - DOI - PMC - PubMed
    1. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Clin Infect Dis. 2018;66(7):987–994. doi: 10.1093/cid/ciy149. - DOI - PubMed
    1. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Clin Infect Dis. 2018;66(7):e1–e48. doi: 10.1093/cid/cix1085. - DOI - PMC - PubMed

LinkOut - more resources